<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Commenti a: Capricor Therapeutics incontrerà l’FDA per discutere dello sviluppo clinico di CAP-1002	</title>
	<atom:link href="https://www.parentproject.it/2018/11/22/capricor-therapeutics-incontrera-lfda-per-discutere-dello-sviluppo-clinico-di-cap-1002/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.parentproject.it/2018/11/22/capricor-therapeutics-incontrera-lfda-per-discutere-dello-sviluppo-clinico-di-cap-1002/</link>
	<description>Insieme per fermare la Duchenne e la Becker</description>
	<lastBuildDate>Thu, 22 Nov 2018 13:50:19 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>
</channel>
</rss>
